DZ2519A1 - Compositions pharmaceutiques comprenant un sensibilisant à l'insuline et un agent antihyperglycémique pour une méthode de traitement du diabéte. - Google Patents

Compositions pharmaceutiques comprenant un sensibilisant à l'insuline et un agent antihyperglycémique pour une méthode de traitement du diabéte.

Info

Publication number
DZ2519A1
DZ2519A1 DZ980129A DZ980129A DZ2519A1 DZ 2519 A1 DZ2519 A1 DZ 2519A1 DZ 980129 A DZ980129 A DZ 980129A DZ 980129 A DZ980129 A DZ 980129A DZ 2519 A1 DZ2519 A1 DZ 2519A1
Authority
DZ
Algeria
Prior art keywords
pharmaceutical compositions
treating diabetes
insulin sensitizer
antihyperglycemic agent
antihyperglycemic
Prior art date
Application number
DZ980129A
Other languages
English (en)
French (fr)
Inventor
Stephen Alistair Smith
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9712865.6A external-priority patent/GB9712865D0/en
Priority claimed from GBGB9806708.5A external-priority patent/GB9806708D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Application granted granted Critical
Publication of DZ2519A1 publication Critical patent/DZ2519A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fodder In General (AREA)
  • Plural Heterocyclic Compounds (AREA)
DZ980129A 1997-06-18 1998-06-17 Compositions pharmaceutiques comprenant un sensibilisant à l'insuline et un agent antihyperglycémique pour une méthode de traitement du diabéte. DZ2519A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9712865.6A GB9712865D0 (en) 1997-06-18 1997-06-18 Novel method of treatment
GBGB9806708.5A GB9806708D0 (en) 1998-03-27 1998-03-27 Novel method

Publications (1)

Publication Number Publication Date
DZ2519A1 true DZ2519A1 (fr) 2003-02-01

Family

ID=26311746

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ980129A DZ2519A1 (fr) 1997-06-18 1998-06-17 Compositions pharmaceutiques comprenant un sensibilisant à l'insuline et un agent antihyperglycémique pour une méthode de traitement du diabéte.

Country Status (24)

Country Link
EP (1) EP0975343A1 (xx)
JP (1) JP2001523271A (xx)
KR (1) KR20010013845A (xx)
CN (1) CN1274282A (xx)
AP (1) AP9901720A0 (xx)
AR (2) AR014881A1 (xx)
AU (1) AU8799998A (xx)
BG (1) BG103966A (xx)
BR (1) BR9810186A (xx)
CA (1) CA2294134A1 (xx)
CO (1) CO4940453A1 (xx)
DZ (1) DZ2519A1 (xx)
EA (1) EA200000040A1 (xx)
IL (1) IL133138A0 (xx)
MA (1) MA26510A1 (xx)
NO (1) NO996270L (xx)
NZ (1) NZ501345A (xx)
OA (1) OA11631A (xx)
PE (1) PE89199A1 (xx)
PL (1) PL337577A1 (xx)
SK (1) SK179499A3 (xx)
TR (1) TR199903072T2 (xx)
UY (1) UY25051A1 (xx)
WO (1) WO1998057635A1 (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0009934A (pt) 1999-04-23 2002-06-04 Smithkline Beecham Plc Produto farmacêutico
CN100577175C (zh) 2001-04-04 2010-01-06 奥索-麦克尼尔药品公司 包括葡萄糖重吸收抑制剂和ppar调节剂的联合疗法
US6838442B2 (en) 2001-04-04 2005-01-04 Ortho-Mcneil Pharmaceutical, Inc. Combination therapy comprising glucose reabsorption inhibitors and retinoid-X receptor modulators
FR2832930A1 (fr) * 2001-12-03 2003-06-06 Lipha Composition pharmaceutique comprenant un inhibiteur d'alpha-glucosidase et un derive de thiazolidinedione et son utilisation pour la preparation de medicaments destines a traiter le diabete
JP2004067575A (ja) * 2002-08-06 2004-03-04 Yaizu Suisankagaku Industry Co Ltd 糖尿病治療薬効果促進剤
CN101121004B (zh) * 2006-08-08 2010-07-21 鲁南制药集团股份有限公司 含有胰岛素增敏剂和米格列醇的药物组合物
CN101584705B (zh) * 2008-05-24 2010-10-27 鲁南制药集团股份有限公司 一种治疗糖尿病及其并发症的药物组合物
CN101584688B (zh) * 2008-05-24 2010-11-10 鲁南制药集团股份有限公司 一种治疗糖尿病及其并发症的药物组合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0601001T3 (da) * 1991-08-26 1997-10-20 Upjohn Co Flydende næringsmiddelprodukt indeholdende 3-guanidinopropionsyre.
US5917052A (en) * 1994-09-28 1999-06-29 Shaman Pharmaceuticals, Inc. Hypoglycemic agent from cryptolepis
TWI238064B (en) * 1995-06-20 2005-08-21 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes

Also Published As

Publication number Publication date
IL133138A0 (en) 2001-03-19
AR013352A1 (es) 2000-12-27
EA200000040A1 (ru) 2000-08-28
NO996270D0 (no) 1999-12-17
OA11631A (en) 2004-11-22
JP2001523271A (ja) 2001-11-20
NZ501345A (en) 2001-10-26
MA26510A1 (fr) 2004-12-20
EP0975343A1 (en) 2000-02-02
PL337577A1 (en) 2000-08-28
WO1998057635A1 (en) 1998-12-23
UY25051A1 (es) 2000-09-29
AU8799998A (en) 1999-01-04
PE89199A1 (es) 1999-10-23
KR20010013845A (ko) 2001-02-26
SK179499A3 (en) 2000-11-07
CN1274282A (zh) 2000-11-22
AP9901720A0 (en) 1999-12-31
BR9810186A (pt) 2000-08-08
TR199903072T2 (xx) 2000-07-21
NO996270L (no) 1999-12-17
AR014881A1 (es) 2001-04-11
CO4940453A1 (es) 2000-07-24
BG103966A (bg) 2000-07-31
CA2294134A1 (en) 1998-12-23

Similar Documents

Publication Publication Date Title
DZ2520A1 (fr) Composition pharmaceutique pour une méthode de traitement du diabète sucré.
DZ2519A1 (fr) Compositions pharmaceutiques comprenant un sensibilisant à l'insuline et un agent antihyperglycémique pour une méthode de traitement du diabéte.
FR2714505B1 (fr) Dispositif et procédé pour générer une image destinée à un traitement graphique d'ordinateur tridimensionnel.
NO973489D0 (no) Stabilisert gassemulsjon inneholdende fosfolipid til kontrastforbedring ved ultralydundersökelser
TNSN96104A1 (fr) Trihydrate de metahensulfonate de (1s,2s)-1-(4-hydroxyphenyl) -2-(4-hydroxy-4-phenylpiperidine-1-yl)-1-propanol et composition pharmaceutique le contenant
MX9703380A (es) Un sistema de computacion para el gerenciamiento de datos y un metodo para operar dicho sistema y, mas particularmente, un sistema de operacion de titulos automatizados (citi-cats-os).
FR2707788B1 (fr) Procédé et appareil pour réduire les discontinuités dans un système d'affichage à adressage actif.
FR2705917B1 (fr) Microtome à aspiration, notamment pour travaux histologiques et similaires.
DZ2521A1 (fr) Compositions pharmaceutiques comprenant de la 5-Ä4-Ä2-(méthyl-n-(2-pyridyl)amino)éthoxyÜbenzylÜ-thiazolidine-2,4-dione et de l'insuline pour une méthode de traitement.
FR2716075B1 (fr) Procédé pour renforcer l'efficacité d'un produit chimique agricole, renforçateur et composition de renforçateur utilisés dans ce procédé et composition chimique agricole comprenant ce renforçateur.
DZ2522A1 (fr) Composition comprenant un sensibilisant à l'insuline et secrétagogue d'insuline pour une méthode de traitement.
DZ1717A1 (fr) Nouvelles compositions pharmaceutiques à base de dérivés de nomegestrol et leur procédés d'obtention.
FR2717000B1 (fr) Dispositif périphérique à clavier et écran pour ordinateur.
MA24607A1 (fr) Compositions comprenant un sensibilisant a l'insuline, un secretagogue d'insuline et un biguanide antihyperglycemique
DE69625315D1 (de) Lichtempfindliche Silberhalogenid-Emulsionen und Verfahren zu ihrer Herstellung
FR2643474B1 (fr) Dispositif pour enregistrer un historique d'execution dans une unite de traitement de l'information
FR2737028B1 (fr) Architecture d'habillage d'applications pour une plate-forme informatique
DZ2564A1 (fr) Compositions pharmaceutiques pour le traitement dudiabète sucre et d'états associés.
DZ2563A1 (fr) Composition contenant un sensibilisant à l'insuline un secrétagogue d'insuline et un biguanide anti-hyperglycérnique inhibiteur d'alpha-glucosidase.
FR2743064B1 (fr) Procede et dispositif de traitement d'un effluent aqueux comprenant une charge organique
FR2848454B1 (fr) Composition pharmaceutique comprenant une association de calcitriol et d'un corticosteroide
MA26758A1 (fr) Composition nouvelle, a liberation modifiee, pour le traitement du diabete.
TNSN97191A1 (fr) Dimesylate de cis-1-(3 ethoxyphenyl)-1-(4-phenyl-piperazine-1- yl)-4- methylcyclohexane, procede pour sa preparation et composition pharmaceutique.
MA26760A1 (fr) Compositions nouvelles de sensibilisants a l'insuline.
MA26759A1 (fr) Composition contenant un sensibilisant a l'insuline, et son utilisation dans le traitement du diabete sucre.